A decrease in the migratory and invasive potential of these androgen-independent prostate cancer cells was achieved also using the flavanonol dihydromyricetin or ampelopsin (Figure 1) via downregulation of the CXCR4 protein expression. This evidence concerns the gene CXCR4 and prostate carcinoma.